Estrogen replacement in surgical stage I and II endometrial cancer survivors
Authors:
- Philip J. DiSaiaPDPhilip J. DiSaia
- Kathryn OsannKOKathryn Osann
- Pat D. RothPRPat D. Roth
- Doug L. GillotteDGDoug L. Gillotte
- Michael L. BermanMBMichael L. Berman
- 1 November 1996
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 175 (5) , 1195-1200
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Staging Laparotomy for Endometrial Carcinoma: Assessment of Retroperitoneal Lymph NodesGynecologic Oncology, 1995
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995
- Development of Endometrial Cancer in Women on Estrogen and Progestin Hormone Replacement TherapyGynecologic Oncology, 1994
- Progestagen supplementation of exogenous oestrogens and risk of endometrial cancerThe Lancet, 1991
- Estrogen replacement therapy following treatment for stage I endometrial carcinomaGynecologic Oncology, 1990
- Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.BMJ, 1989
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Effect of the Fluoride/Calcium Regimen on Vertebral Fracture Occurrence in Postmenopausal OsteoporosisNew England Journal of Medicine, 1982
- MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1981
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976